Numerion Labs
Artificial intelligence for drug discovery.
Operating in healthcare based in San Francisco, CA, USA, Numerion Labs operates.
Profile
Numerion Labs is an AI-native company accelerating the discovery of life-saving medicines through the development and use of cutting-edge machine learning algorithms. The company unites computational chemistry, structural biology, and medicinal chemistry to pioneer the next generation of AI-driven drug discovery platforms.
Within the healthcare space, the company focuses on its core offering rather than a broad product line.
San Francisco, CA, USA is where the company is located.
Directory data places it at the Winter 2015 stage.
The company reports a headcount in the 67 range.
Directory analysis
Numerion Labs is an AI-native biotech firm based in San Francisco that focuses on accelerating drug discovery using machine learning. The company blends computational chemistry, structural biology, and medicinal chemistry to build AI-driven platforms for identifying life‑saving medicines. With a team of 67 employees, Numerion Labs positions itself at the intersection of AI and early‑stage pharmaceutical research.
Positioning: Numerion Labs operates in the competitive AI‑driven drug discovery space, targeting pharmaceutical and biotech partners seeking computational acceleration of lead identification. Its multidisciplinary approach aims to differentiate it from traditional medicinal chemistry workflows, though market adoption depends on demonstrating tangible speed and cost advantages.
Note: Numerion Labs leverages AI to speed up early‑stage drug discovery and collaborates across computational chemistry, structural biology, and medicinal chemistry.
Auto-generated directory analysis from public data · updated 6 Oct 2026. Informational only, not investment advice.
| Sector | Healthcare |
|---|---|
| Headquarters | San Francisco, CA, USA |
| Country | USA |
| Employees | 67 |
| Stage | Winter 2015 |
Website: www.numerionlabs.ai
Browse related
Create a free account